PDL2

PDL2

(language)
This article is provided by FOLDOC - Free Online Dictionary of Computing (foldoc.org)
References in periodicals archive ?
Abbreviations: CD, cluster of differentiation; CTLA4, cytotoxic T-lymphocyte-associated protein 4; MHC, major histocompatibility complex; PD-1, programmed death receptor-1 (programmed death- ligand 1 receptor); PD-L1, programmed death ligand-1; PDL2, programmed death ligand-2; TAA, tumor associated antigen; TCR, T-cell receptor.
Chen et al., "Severe tuberculosis induces unbalanced up-regulation ofgene networks and overexpression of IL-22, MIP-1[alpha], CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-[beta], TIM1, and TLR2 but low antigen-specific cellular responses," The Journal of Infectious Diseases, vol.
The PD-1 ligands, i.e., PD-L1 and PDL2, are extensively expressed on various cells, including T cells, B cells, dendritic cells and macrophages [34, 35].
The proliferation and effector functions of T cell can be inhibited via the binding of PDL1 or PDL2 to PD1 on its surface [7].
brasiliensis infection increases type 2 cell-mediated cytokine responses in the lung, further indicating that AAMs inhibit Th2 cells by expression of PDL2. In addition to its effector function, PD-L2 is used as a relevant surface marker to distinguish between resident and monocyte-derived macrophages following antigenic stimulation or S.
It is the first time the young Sky Blues have won the title in the club's history, and they now march on to a semi final play-off with PDL2 North champions Sheffield Wednesday at the Alan Higgs Centre on Saturday.
It is a negative regulator of the immune system that functions by forming a complex with its ligands (either PDL1 or PDL2).
BLUES U23s 0 WATFORD U23s 1 BLUES' Under-23s were left ruing a host of missed opportunities as they started their PDL2 campaign with an inexplicable defeat.
After the regular PDL2 season, the top two sides from the northern and southern divisions go into the play-offs to determine the overall champion.
These membrane proteins include PDL1 and PDL2, and represent some of the key targets for the development of immunotherapy by pharmaceutical companies.
PD-1 receptor has two ligands: PD-L1 (also known as B7-H1 or CD274) and PDL2 (also called B7-DC or CD273).